KUROS BIOSCIENCES AG NAM.-AKTIEN/ CH0325814116 /
| 2024-11-16 1:04:01 PM | Chg. 0.000 | Volume | Bid1:04:01 PM | Ask1:04:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 26.600EUR | 0.00% | - Turnover: - |
26.600Bid Size: - | 26.900Ask Size: - | 975.47 mill.EUR | - | - |
Assets
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | .6000 | .6000 | .5000 | .5000 | ||||||
| Intangible Assets | 6.6000 | 33.2000 | 31.1000 | 27.9000 | 23.7000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 30.4000 | 68.4000 | 66 | 64.6000 | 60.4000 | ||||||
| Inventories | 0.0000 | .2000 | .4000 | .5000 | .5000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 12.4000 | 16.7000 | 18.3000 | 20.8000 | 28.4000 | ||||||
| Current Assets | 13.4000 | 17.7000 | 19.8000 | 23.3000 | 34 | ||||||
| Total Assets | 43.8000 | 86.1000 | 85.8000 | 87.9000 | 94.4000 | ||||||
Liabilities
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.3000 | 1.3000 | 1.6000 | 1.1000 | .9000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 2 | 1.7000 | 2.1000 | 2.3000 | 2.7000 | ||||||
| Liabilities | 5.4000 | 12.9000 | 9.3000 | 10 | 9.8000 | ||||||
| Share Capital | 5.1000 | 8.2000 | 15.1000 | 22.5000 | 32.8000 | ||||||
| Total Equity | 38.3000 | 73.1000 | 76.5000 | 77.9000 | 84.6000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 43.8000 | 86.1000 | 85.8000 | 87.9000 | 94.4000 | ||||||
Income Statement
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1.1000 | .5000 | .7000 | 2.6000 | 4 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -21.3000 | -16.2000 | -13.7000 | -11.4000 | -13.4000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -20.3000 | -16.6000 | -13.8000 | -11.8000 | -12.1000 | ||||||
| Income Taxes | .6000 | .1000 | 2.1000 | .5000 | .6000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -19.7000 | -16.5000 | -11.7000 | -11.3000 | -11.5000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -8.9000 | -10.7000 | -12.8000 | -10.8000 | -9.2000 | ||||||
| Cash Flow from Investing Activities | 1.8000 | -.9000 | -.7000 | -.1000 | -.2000 | ||||||
| Cash Flow from Financing | 3.5000 | 16 | 15 | 13.1000 | 17.1000 | ||||||
| Decrease / Increase in Cash | -3.6000 | 4.4000 | 1.5000 | 2.2000 | 7.6000 | ||||||
| Employees | 16 | 28 | 9 | 6 | 5 | ||||||
